ALLO - Allogene Therapeutics, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
5/20/24 21:33	5/16/24	ALLO	Health	BioPrd	Biological Products, (No Diag	Belldegrun Arie	CA	D		P	5,000	2.90	1,724	21	10,099	I
3/6/24 21:52	1/30/24	ALLO	Health	BioPrd	Biological Products, (No Diag	Parker Geoffrey M.		O	CFO	P	1	3.60	0	0	820	D
1/14/22 14:13	1/12/22	ALLO	Health	BioPrd	Biological Products, (No Diag	Kazam Joshua A	CA	D		P	189	12.60	15	6	259	D
1/14/22 12:02	1/12/22	ALLO	Health	BioPrd	Biological Products, (No Diag	Belldegrun Arie	CA	D		P	1,953	12.60	155	2	7,075	I
6/4/20 16:04	6/4/20	ALLO	Health	BioPrd	Biological Products, (No Diag	Belldegrun Arie	CA	D		P	6,880	47.00	146	2	6,447	I
2/13/19 17:10	10/15/18	ALLO	Health	BioPrd	Biological Products, (No Diag	Belldegrun Arie	CA	D		P.a	3,500	18.00	194	13	1,692	I
10/17/18 17:32	10/15/18	ALLO	Health	BioPrd	Biological Products, (No Diag	Witte Owen N.	CA	D		P.d	270	18.00	15	7	236	D
10/17/18 17:32	10/15/18	ALLO	Health	BioPrd	Biological Products, (No Diag	Humer Franz B	CA	D		P.d	540	18.00	30	40	105	D
10/17/18 17:30	10/15/18	ALLO	Health	BioPrd	Biological Products, (No Diag	Chang David D	CA	DO	P,CEO	P.d	720	18.00	40	1	4,794	M
10/17/18 17:29	10/15/18	ALLO	Health	BioPrd	Biological Products, (No Diag	Belldegrun Arie	CA	DT		P.d	630	18.00	35	2	2,021	M
10/17/18 17:17	10/15/18	ALLO	Health	Drug	Pharmaceutical Preparations	Pfizer Inc	NY	T		P.d	1,000	18.00	56	0	22,032	D
10/17/18 17:10	10/15/18	ALLO	Health	BioPrd	Biological Products, (No Diag	Tpg Group Holdings (Sbs) Advisors, Inc.	TX	T		P.d	12,150	18.00	675	3	23,135	I

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person